跳至主要内容
临床试验/NCT05491980
NCT05491980进行中(未招募)不适用

Creating a Florida Cerebrovascular Disease Biorepository and Genomics Center

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2022年8月2日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Mayo Clinic
入组人数
72
试验地点
1
主要终点
Stroke or TIA at 12 months

研究概览

简要总结

The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting medical history information and blood from subjects affected by cerebrovascular disease. The information and blood samples collected may be used in future research for the study of cerebrovascular disease and to learn about, prevent or treat other health problems.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Affected subjects with diverse cerebrovascular conditions, including, but not limited to, ischemic stroke, transient ischemic attack (TIA), intracerebral hemorrhage (ICH), aneurysmal subarachnoid hemorrhage (aSAH), vascular dementia (VAD), anoxic brain injury, unruptured intracranial aneurysm (UIA), cavernous malformation, arteriovenous malformations (AVM), carotid and vertebral arterial dissections, symptomatic and asymptomatic cervical carotid artery atherosclerotic stenosis, non-aneurysmal perimesencephalic subarachnoid hemorrhage (naSAH), cerebral venous thrombosis (CVT), moyamoya disease, fibrosmuscular dysplasia (FMD), non-traumatic, angiography-negative subarachnoid hemorrhage, leukoaraiosis, arteriovenous fistula, reversible cerebral vasoconstriction syndrome (RCVS), and CADASIL.

排除标准

  • All patients with the following known or suspected virulent microorganisms causing an active or latent infection will be excluded from the study:
  • Human immunodeficiency virus (HIV);
  • Any viral hepatitis;
  • West Nile virus (WNV);
  • Influenza virus;
  • Tuberculosis (TB);
  • Any bacteremia;
  • Any fungemia;
  • Any prionopathy.

结局指标

主要结局

Stroke or TIA at 12 months

时间窗: 1 year

Number of participants to experience new diagnosis of TIA or stroke.

次要结局

  • Modified Rankin Scale(1 year)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

James F. Meschia

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验